ArticleArchives of medical science : AMS2012

Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option?

Magdalena Zaborowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.